176
Participants
Start Date
November 14, 2022
Primary Completion Date
March 14, 2025
Study Completion Date
July 10, 2026
Retifanlimab
Retifanlimab 500mg will be administered intravenously every 4 weeks.
INCAGN02385
INCAGN02385 350mg will be administered intravenously every 2 weeks.
INCAGN02390
INCAGN02390 400 mg will be administered intravenously every 2 weeks.
Placebo
Placebo will be administered intravenously.
National Taiwan University Hospital, Taipei
Fondazione Del Piemonte Per L Oncologia Ircc Candiolo, Candiolo
University Hospital of West Attica - Attikon, Chaïdári
Cha Bundang Medical Center, Seongnam-si
Ico Girona Hospital Universitari de Girona Dr Josep Trueta, Girona
Fox Chase Cancer Center, Philadelphia
Georgetown University, Washington D.C.
Fondazione Irccs Istituto Nazionale Del Tumori Di Milano, Milan
European Institute of Oncology, Milan
Universitatsklinikum Hamburg Eppendorf, Hamburg
University of Maryland-Greenebaum Cancer Center, Baltimore
Asklepios Klinik Altona, Hamburg
University of Virginia - Emily Couric Clinical Cancer Center, Charlottesville
Fondazione Irccs Policlinico San Matteo, Pavia
Hospital Universitario Ramon Y Cajal, Madrid
Hospital Universitario Quironsalud Madrid, Madrid
Hospital Regional Universitario Carlos Haya, Málaga
Complejo Hospitalario de Navarra, Pamplona
Mayo Clinic Jacksonville, Jacksonville
Centre Hospitalier Universitaire de Bordeaux, Bordeaux
Blessed Health Care, Miami
Centre Eugene Marquis, Rennes
Iov - Istituto Oncologico Veneto Irccs, Padua
Hospital Universitario Marques de Valdecilla, Santander
Ausl-Irccs Di Reggio Emilia, Reggio Emilia
Centre de Lutte Contre Le Cancer - Institut de Cancerologie de L'Ouest - Rene Gauducheau, Saint-Herblain
Hospital General Universitario de Valencia, Valencia
Hospital Universitari I Politecnic La Fe, Valencia
University of Michigan Cancer Center, Ann Arbor
Barbara Ann Karmanos Cancer Hospital, Detroit
Pusan National University Yangsan Hospital, Busan
Pusan National University Yangsan Hospital, Yangsan
University of Cologne, Cologne
Theagenio Anticancer Hospital, Thessaloniki
Bioclinic Thessaloniki (Galinos Clinic), Thessaloniki
Universitatsmedizin Der Johannes Gutenberg-Universitat Mainz Iii, Mainz
Saint Lukas Clinic, Thessaloniki
Chonnam National University Hwasun Hospital, Gwangju
University of Illinois At Chicago, Chicago
University of Kansas Hospital Authority, Kansas City
Icans - Institut de Cancerologie Strasbourg Europe, Strasbourg
Institut Curie, Paris
Istituto Nazionale Tumori Irccs Fondazione Pascale, Naples
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City
Chang Gung Medical Foundation. Kaohsiung Branch, Kaohsiung City
Huntsman Cancer Institute At University of Utah, Salt Lake City
Mayo Clinic Rochester, Scottsdale
Innovative Clinical Research Institute, Long Beach
City of Hope National Medical Center, Long Beach
University of California San Diego Medical Center, Moores Cancer Center, La Jolla
City of Hope Orange County, Irvine
City of Hope-Antelope Valley, Lancaster
University of California San Francisco Comprehensive Cancer Center, San Francisco
Kadlec Clinic Hematology and Oncology, Kennewick
City of Hope National Medical Center, Duarte
Moffitt Cancer Center, Tampa
University of Iowa, Iowa City
Dana Farber Cancer Institute, Boston
Hackensack University Medical Center, Hackensack
Grand Hospital de Charleroi, Charleroi
Jessa Ziekenhuis, Hasselt
Gza Sint Augustinus, Wilrijk
McGill University Health Centre/Glen Site/Cedars Cancer Centre, Montreal
Chum Hospital Notre Dame, Montreal
McGill University Jewish General Hospital, Montreal
Jsc Evex Hospitals, K'ut'aisi
New Hospitals, Tbilisi
Jsc Evex Corporation-Caraps Medline, Tbilisi
Ltd Cancer Research Centre, Tbilisi
The Dutch Cancer Institue, Amsterdam
Leids Universitair Medisch Centrum (Lumc) (Leiden University Medical Center), Leiden
Centrum Onkologii Im. Prof. Franciszka Lukaszczyka, Bydgoszcz
Przychodnia Lekarska Komed Roman Karaszewski, Konin
Centrum Onkologii Ziemi Lubelskiej Im. SW. Jana Z Dukli, Lublin
Poznan University of Medical Sciences, Poznan
Nzoz Provita Prolife Centrum Medyczne, Tomaszów Mazowiecki
Centrum Onkologii - Instytut Im. Marii Sklodowskiej - Curie, Warsaw
Hospital de Braga, Braga
Centro Hospitalar Universitario Algarve, Faro
Centro Hospitalar de Lisboa Norte E.P.E. - Hospital de Santa Maria, Lisbon
Instituto Portugues de Oncologia Do Porto Francisco Gentil E.P.E., Porto
Centro Hospitalar de Sao Joao Alameda, Porto
Centro Hospitalar de Vila Nova de Gaia/Espinho, Epe-Unidade L, Vila Nova de Gaia
Korea University Anam Hospital, Seoul
Kangbuk Samsung Hospital, Seoul
Kunkuk University Medical Center, Seoul
Asan Medical Center, Seoul
Catalans Institute of Oncology Barcelona, Barcelona
Fundacion Jimenez Diaz University Hospital, Madrid
China Medical University Hospital, Taichung
Institutional Review Board Taipei Veterans General Hospital, Taipei
Lead Sponsor
Incyte Biosciences International Sàrl
INDUSTRY